MaxCyte financials
$1.18+1.72%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3M | $9.7M | $7.3M | $6.8M | $8.5M | $10.4M | $8.7M | $8.2M | $10.4M | $11.3M | $15.7M | $8.0M |
| Gross profit | $5.6M | $8.1M | $5.7M | $5.2M | $7.0M | $8.9M | $6.4M | $6.2M | $8.9M | $9.9M | $14.1M | $7.2M |
| Gross margin | 77.0% | 83.7% | 77.9% | 76.6% | 82.1% | 85.6% | 73.8% | 76.4% | 85.7% | 87.6% | 90.0% | 90.1% |
| Operating income | -$10.2M | -$6.2M | -$11.2M | -$14.1M | -$14.2M | -$12.3M | -$12.9M | -$14.1M | -$12.0M | -$12.3M | -$8.1M | -$14.0M |
| Net income | -$8.9M | -$4.8M | -$9.6M | -$12.4M | -$12.4M | -$10.3M | -$10.6M | -$11.6M | -$9.4M | -$9.5M | -$5.3M | -$11.3M |
| Net margin | −122.0% | −49.2% | −131.5% | −181.8% | −145.3% | −98.8% | −121.9% | −141.6% | −89.9% | −84.0% | −33.7% | −140.6% |
| Diluted EPS | $-0.08 | $-0.04 | $-0.09 | $-0.12 | $-0.12 | $-0.10 | $-0.10 | $-0.11 | $-0.09 | $-0.09 | $-0.05 | $-0.11 |
| EBITDA | -$9.3M | -$5.1M | -$3.5M | -$13.1M | -$13.1M | -$11.2M | -$11.8M | -$13.0M | -$10.9M | -$11.2M | -$7.0M | -$12.9M |
| Operating cash flow | -$4.7M | -$8.2M | -$2.7M | -$7.5M | -$9.9M | -$14.4M | -$7.8M | -$4.4M | -$4.8M | -$10.6M | $981.0K | -$8.2M |
| Free cash flow | -$4.7M | -$8.2M | -$2.9M | -$7.8M | -$10.4M | -$15.1M | -$8.0M | -$4.8M | -$5.1M | -$11.4M | $66.0K | -$9.0M |
| Diluted shares | 106.8M | 106.9M | 106.7M | 106.6M | 106.4M | 106.0M | 105.6M | 105.1M | 104.6M | 104.1M | 103.7M | 103.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.0M | $14.6M | $20.1M | $13.0M | $15.2M | $23.4M |
| Short-term investments | $90.6M | $92.3M | $83.0M | $92.8M | $111.3M | $114.9M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $184.7M | $194.5M | $202.5M | $213.5M | $219.8M | $230.0M |
| Total liabilities | $25.9M | $26.6M | $31.0M | $33.2M | $29.0M | $30.5M |
| Shareholders' equity | $158.8M | $167.9M | $171.5M | $180.3M | $190.7M | $199.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology